Vanessa Brady
Director, Global Environmental, Health, Safety, & Sustainability Charles River Laboratories
Seminars
In today’s volatile biopharma landscape, effective EHS leadership demands adaptability, foresight, and influence. This interactive workshop equips global leaders to navigate shifting regulations, tightening
budgets, and organisational flux while sustaining a strong safety culture. Through peer exchange and scenario-led discussion, participants will learn how to lead with flexibility, maintain global alignment, and position EHS as a driver of trust, continuity, and performance.
Key Questions to Be Addressed
- How can senior leaders anticipate regulatory shifts and build foresight into strategy before compliance pressures force reactive change?
- What leadership behaviours and governance models enable standardisation with local autonomy across diverse regions and risk profiles?
- How can EHS priorities remain visible and adequately funded when capital is scarce, and business pressures dominate executive decision-making?
- What communication strategies help reposition EHS from a compliance function to a value-creating partner in business resilience and innovation?
- How can leaders foster psychological safety and engagement, so teams stay motivated, accountable, and adaptive during constant change?
- Explore how fragmented standards, inconsistent oversight, and cost-driven pressures across contractors and suppliers create vulnerabilities in EHS performance, addressing prequalification, third-party assurance, and the opportunity for industrywide alignment on safety expectations and ethical contracting
- Demonstrate how collaboration across biopharma companies can establish shared standards, reduce duplication, and strengthen cultural consistency across complex global supply chains
- Gain strategies to implement unified contractor management frameworks, balance cost and safety incentives, and foster long-term partnerships that enhance both compliance and worker wellbeing